How do you translate the diabetes mellitus type 2 and hypertension guidelines into real practice? Register your interest in this EACCME® accredited independently-led webinar.
Live Webinar Agenda
|Cardiovascular Metabolism Webinar Agenda
Type 2 Diabetes & Hypertension: Guidelines, practicalities and pitfalls to avoid
Thursday, 28th January 2021, 10:00-11:00 CET
|Chair: Dr Kevin Fernando|
|Welcome and introductions||Dr Kevin Fernando (UK)|
|Type 2 diabetes & hypertension: Guidelines versus individualised care||Dr Kevin Fernando (UK)|
|Diabetes: How has the evidence impacted guidelines in management of T2DM||Professor Melanie Davies (UK)|
|Hypertension: Should we go beyond the guidelines?||Professor Luis Ruilope (Spain)|
|Panel discussion and Q&A||All|
|Closing statements||Dr Kevin Fernando (UK)|
This concise and timely EACCME® accredited webinar brings you the unique opportunity to gain practical advice from a GP perspective, alongside expert insights, to help you translate diabetes mellitus type 2 and hypertension guideline updates into real practice.
An unmissable opportunity to gain practical advice from a GP and expert perspective
Our GP Dr Kevin Fernando, together with our experts Professor Melanie Davies and Professor Luis Ruilope will discuss the clinical unmet needs in diabetes mellitus type 2 and hypertension, the diagnosis and implications of co-morbid diabetes mellitus type 2 and hypertension, practical advice on treatment, pitfalls to avoid, and the importance of a patient-centred yet evidence-informed approach.
Our experts will also come together for a live panel discussion, where they will discuss a realistic patient case study and answer questions on clinical inertia, medications, identifying red flags, and more. Don’t miss out!
Professor Luis M. Ruilope
Professor Ruilope works at the Public Health and Preventive Medicine department of the Autonoma University and is head of Cardiovascular and Renal Risk at Instituto de Investigación 12 de Octubre, both in Madrid, Spain. His main interested fields are Hypertension and Cardiovascular Risk.
Developed by EPG Health for Medthority. This content has been developed independently of the sponsor Novartis Pharma AG, who have had no editorial input into the content. EPG Health received unrestricted educational funding from the sponsor in order to help provide its healthcare professional members with access to the highest quality medical and scientific information, education and associated relevant content.